InstalabFractionated Free Metanephrines
Should you take a Fractionated Free Metanephrines test?
This test is most useful if any of these apply to you.
3 biomarkers included
- Free MetanephrinesTracks the leftover of adrenaline, which is made almost only inside adrenal tissue. Its presence tells you which pathway the tumor favors.Why it mattersA clear rise points toward an adrenaline-producing tumor sitting in an adrenal gland rather than elsewhere in the body.
- Free NormetanephrinesTracks the leftover of noradrenaline, the hormone most of these tumors overproduce. It is the marker most likely to be abnormal and often the only one that rises.Why it mattersFrequently the single abnormal result when a tumor is present, and the main clue to a tumor outside the adrenal gland.
- Total Free (MN+NMN)Adds the two markers into a single figure for overall hormone load. The combined amount tends to rise with tumor size.Why it mattersA markedly high combined value tracks with larger tumor burden and makes a true tumor far more likely than a borderline reading.
About Fractionated Free Metanephrines
Some of the most dramatic blood pressure problems trace back to a tumor most people will never hear of. These growths pump out fight-or-flight hormones on their own schedule, triggering pounding headaches, drenching sweats, a racing heart, and blood pressure that shrugs off medication. This panel is the way to find them early.
The catch is that these tumors release their hormones in bursts, so the hormones themselves can read normal between episodes. This panel measures the steady breakdown products instead, which the tumor leaks around the clock. That is why major guidelines make it the first test to run.
What This Panel Reveals
This panel answers one question: is your body carrying a tumor that overproduces stress hormones? The tumors in question are rare growths of the adrenal glands and nerve clusters (called pheochromocytomas and paragangliomas). They flood the bloodstream with adrenaline-family chemicals, and the body converts those chemicals into stable leftovers that this panel can measure.
The value comes from splitting the signal in two. One marker tracks the leftover of adrenaline (called metanephrine). The other tracks the leftover of noradrenaline (called normetanephrine). A third value simply adds the two together to show the total load. Measuring them separately does something a single combined number cannot: it shows which hormone pathway the tumor favors, which in turn hints at where the tumor sits and how it is wired.
The reason this beats measuring the hormones directly is timing. The tumor produces these breakdown products continuously, so they do not fade between symptom spells the way the parent hormones do. In a prospective study of 2,056 people, this plasma approach detected tumors with 97.9% sensitivity at 94.2% specificity, outperforming urine-based testing in higher-risk patients.
How to Read Your Results Together
The pattern between the two markers, not just whether one is high, carries the meaning. Use these combinations as a starting map.
| Result Pattern | What It Suggests |
|---|---|
| Normetanephrine high, metanephrine normal | A noradrenaline-producing tumor. Common pattern, often a tumor outside the adrenal gland or tied to certain inherited types. |
| Both elevated, with a clear metanephrine rise | An adrenaline-producing tumor, which points strongly toward an adrenal gland location. |
| Either marker more than 3 to 4 times above the upper limit | Rarely a false alarm. A true tumor is very likely and imaging is the next step. |
| Mild normetanephrine bump only | The most common false positive. Sampling conditions and medications should be reviewed before anything else. |
Magnitude matters as much as pattern. A value three to four times above the normal ceiling is almost never seen in people without a tumor, while a small single-marker bump usually reflects something other than a tumor. The combined total also tracks with tumor size, so a markedly high sum raises concern more than a borderline one.
What to Do with Your Results
A mild elevation, especially of normetanephrine alone, is not a diagnosis. The right move is to repeat the test drawn lying down after resting, and to review any medications or recent stress that could push the number up. Only after a clean repeat should the result be treated as real.
A large elevation, or both markers rising together, warrants prompt follow-up with an endocrinologist and imaging to locate the tumor. Because these tumors sometimes run in families, a positive result is also a reason to discuss genetic testing. If you have already had one removed, this panel is the backbone of long-term monitoring: guidelines recommend a first check in the weeks to months after surgery to confirm the tumor is gone, then at least yearly for a decade, and lifelong for higher-risk cases, since these tumors can return years later, with reported recurrence rates ranging from roughly 3% to 15% depending on tumor type, size, and whether it is hereditary.
When Results Can Be Misleading
Several factors can raise both markers at once and fake a positive. Blood drawn while seated instead of lying down is a leading cause; one study found outpatient sampling produced 44% higher normetanephrine and a 3.4-fold jump in false positives. Acute illness, stress, poor kidney function, and older age all nudge values upward, and normetanephrine naturally climbs with age.
Medications are the other big confounder. Acetaminophen can interfere with some older lab methods, and antidepressants such as tricyclics and certain newer agents can raise levels through their effect on hormone handling. Because these tumors turn up in only a small share of people tested, often well under 1% when screening is prompted by symptoms alone, false positives outnumber true ones, which is exactly why one abnormal value is a prompt to investigate, not to conclude.